Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

mint Lesion screenshot with PET evaluation, SUV, customized response criteria

Customizable reading templates for therapy response assessment

mint Lesion offers customizable reading templates for therapy response assessment in clinical care and research. Adapt parameters, define lesion categories, and evaluate responses. Track key measurements like diameter, volume, SUV, and ADC, ensuring compliance with required minimum sizes. Automate sum calculations for response determination and integrate clinical data such as ctDNA or PSA values. Document multiple lesions, compare absolute and relative changes over time, and visualize trends with interactive charts. Generate comprehensive reports with tables and graphs for a clear longitudinal overview.

Key features:

  • Easily customizable parameters
    • Questions for manual response evaluation
    • Lesion categories (e.g., target lesions, non-target lesions)
    • System-derived lesion states (e.g., normalized for lymph nodes)
    • Key measurement values (e.g., longest diameter, short axis, volume, SUV, ADC, etc.), including required minimum size for each lesion category
    • Sum of measurements for response determination (e.g., sum of diameter or sum of volume)
    • Clinical data (e.g., ctDNA or PSA values)
  • Ability to document the count of multiple (non-target and new) lesions
  • Automatic calculations of absolute and relative differences to baseline, previous timepoint and nadir
  • Interactive charts displaying all relevant values over time, including clinical data, with dynamic filtering options
  • Comprehensive reports including tables and graphs for a fast and clear longitudinal overview

Related Resources

Related Resources

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

A picture of a person looking at a brain scan and the interface of mint Lesion™  on a computer

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™

Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…

A picture of radiologists looking at a screen showing the restaging of the HNSCC

Study Highlights the Potential of Radiomics in Medical Intervention

A recent study conducted by the Medical University of Innsbruck highlights the potential of radiomics in exploring the impacts of Radiochemotherapy…